Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
about
OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDERecent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats.Treatment of androgen excess in females: yesterday, today and tomorrow.Partial sequencing and tissue distribution of the canine isoforms of steroid 5alpha-reductase type I and type II.
P2860
Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@ast
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@en
Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride
@nl
type
label
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@ast
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@en
Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride
@nl
prefLabel
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@ast
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@en
Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride
@nl
P2093
P1476
Endocrine properties of the te ...... bitor turosteride (FCE 26073).
@en
P2093
P304
P356
10.1016/0960-0760(94)90151-1
P577
1994-02-01T00:00:00Z